• Jauhar Mumtaz Khan PAF Hospital , PAF Base Faisal
  • Muhammad Usman Rathore Najran Armed Forces Hospital KSA
  • Moizza Tahir CMH Multan
  • Tariq Abbasi Ayub Medical Complex


Background: Patient suffering from psoriasis can be severely affected in their day to day activities and it may also result in reduced work efficiency and absenteeism from work leading to financial burden on the patient’s family. This study was conducted using Dermatology Life Quality Index to assess the quality of life of a patient suffering from psoriasis being treated at a military hospital. Methods: This cross-sectional study was conducted in the outpatient unit of Department of Dermatology, Combined Military Hospital Abbottabad from 1st October 2013 to 31stJune 2014. The demographic data and Dermatology Life Quality Index of patients of psoriasis were recorded using a standard questionnaire and their final score was calculated to assess the effect of disease on patient’s life. Extent/ severity of disease was assessed according to the body surface area involved. The data was analysed using SPSS-18. Mean and SD for numerical variables and frequencies and percentages for categorical were calculated. Results: A total of 160 patients fulfilling the inclusion criteria were included in the study. Mean age of the patients was 40.48 years (±12.58 years) with minimum age of 18 years and maximum of 74 years. 118 patients were males were (73.8%) and 42 were females (26.2%). Twenty (12.5%) patients had no effect on their life by the disease while 5 (3.1%) had extremely large effect. Most patients, i.e., 68 (42.5%) had moderate effect on their lives. 69 patients had mild psoriasis as per body surface area involved, 70 had moderate disease and 21 had severe disease. Conclusion: Psoriasis affects quality of life of patients not only physically but also psychologically and financially even when patients are under treatment. Psychological aspects also need to be addressed while treating the physical morbidity.Keywords: Psoriasis; quality of life; Social; Dermatology Life Quality Index; body surface area

Author Biographies

Jauhar Mumtaz Khan, PAF Hospital , PAF Base Faisal

Consultant Dermatologist

Muhammad Usman Rathore, Najran Armed Forces Hospital KSA

Consultant Histopathology

Moizza Tahir, CMH Multan

Associate Professor Dermatology

Tariq Abbasi, Ayub Medical Complex

Assistant Professor Anesthesiology


Rohini G, Sharmishtha D, Swati R, Dhamdhere DV, Ghate MR. Evaluation of functional impairment in psoriasis. Indian J Dermatol Venereol Leprol 2006;72(1):37–40.

Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes 2006;4:35.

Nasreen S, Ahmed I, Effendi S. Frequency and magnitude of anxiety and depression in patients with Psoriasis Vulgaris. J Coll Physicians Surg Pak 2008;18(7):397–400.

Unaeze J, Nijsten T, Murphy A, Ravichandran C, Stern RS. Impact of Psoriasis on Health-Related Quality of Life Decreases Over Time: An 11-Year Prospective Study. J Invest Dermatol 2006;126(7):1480–89.

Ludwig MW, Oliveira MS, Muller MC, Moraes JF. Quality of life and site of the lesion in dermatological patients. An Bras Dermatol 2009;84(2):143–50.

Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005;64(Suppl 2):ii18–23.

Shikiar R, Willian MK, Okun MM, Thompson CS, Revicki DA. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual Life Outcomes 2006;4:71.

Llamas-Velasco M, de la Cueva P, Notario J, Martìnez-Pilar L, Martorell A, Moreno-Ramìrez D. Moderate Psoriasis: A Proposed Definition. Actas Dermosifiliogr 2017;108(10):911–7.

Rencz F, Poór AK, Péntek M, Holló P, Kárpáti S, Gulácsi L, et al. A detailed analysis of ‘not relevant’ responses on the DLQI in psoriasis: potential biases in treatment decisions. J Eur Acad Dermatol Venereol 2018;32(5):783–90.

Poór AK, Brodszky V, Péntek M, Gulácsi L, Ruzsa G, Hidvégi B, et al. Is DLQI appropriate for medical decision making in psoriasis patients? Arch Dermatol Res 2018;310(1):47–55.

Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19(3):210–6.

Finlay AK, Khan GK. Dermatology Quality of Life Index (DQLI). [Internet]. 1991 Apr [Cited 2019 Feb 2]. Available from:

Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology LifeQuality Index 1994-2007: a comprehensive review of validation data andclinical results. Br J Dermatol 2008;159(5):997–1035.

Chang CC, Gangaram HB, Hussein SH. Malaysian Psoriasis Registry-preliminary report of a pilot study using a newly revised registry form. Med J Malaysia 2008;63(Suppl C):68–71.

Khan SA, Shaikh ZI. Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI): The correlation between disease and severity and quality of life in patients of psoriasis. Pak Armed Forces Med J 2007;67(6):1058–62.

Çakmur H, Derviş H. The relationship between quality of life and the severity of psoriasis in Turkey. Eur J Dermatol 2015;25(2):169–76.

de Rie MA, de Hoop D, Jӧnsson L, Bakkers EJ, Sorensen M. Pharmacoeconomic evaluation of calcipotriol and UVB phototherapy in the treatment of psoriasis: a Markov model for the Netherlands. Dermatology 2001;202(1):38–43.



Most read articles by the same author(s)